Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)
Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%
Dr Reddys Laboratories cash
Cash and short-term investments held at the end of each period.
Dr Reddys Laboratories's cash was ₹15.37B at Mar 31, 2026. For fiscal 2026 it was ₹15.37B, up 4.9% from the year before. The highest annual figure on record is ₹15.37B in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ₹15.37B | +4.9% |
| FY2025 | Mar 31, 2025 | ₹14.65B | +106.2% |
| FY2024 | Mar 31, 2024 | ₹7.11B | +23.0% |
| FY2023 | Mar 31, 2023 | ₹5.78B | -61.1% |
| FY2022 | Mar 31, 2022 | ₹14.85B | +0.2% |
| FY2021 | Mar 31, 2021 | ₹14.83B | +622.3% |
| FY2020 | Mar 31, 2020 | ₹2.05B | -7.9% |
| FY2019 | Mar 31, 2019 | ₹2.23B | -15.5% |
| FY2018 | Mar 31, 2018 | ₹2.64B | -31.8% |
| FY2017 | Mar 31, 2017 | ₹3.87B | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | ₹15.37B | +3.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | ₹14.65B | -1.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | ₹7.11B | +246.2% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | ₹5.78B | +159.4% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | ₹14.85B | +463.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | ₹14.83B | +283.6% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | ₹2.05B | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | ₹2.23B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | ₹2.64B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | ₹3.87B | – |
See a number that looks wrong?